• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉推注和顺铂静脉输注后大鼠组织中铂的定量亚细胞分布。

Quantitative subcellular distribution of platinum in rat tissues following i.v. bolus and i.v. infusion of cisplatin.

作者信息

Parti R, Wolf W

机构信息

Radiopharmacy Program, University of Southern California, Los Angeles 90033.

出版信息

Cancer Chemother Pharmacol. 1990;26(3):188-92. doi: 10.1007/BF02897197.

DOI:10.1007/BF02897197
PMID:2357765
Abstract

An analysis of the subcellular localization of platinum was conducted in Sprague-Dawley (SD) rats following administration of an i.v. dose of 6 mg/kg cisplatin (bolus and infusion). Biodistribution studies were carried out in the liver and kidney of control animals, as well as in these same organs and in the tumor (Walker 256 adenocarcinoma) of SD rats. The results obtained illustrate that in addition to the platination of DNA in these tissues, significant amounts of Pt are also incorporated into the chromosomal protein (CP) and cytosolic fractions. The localization of Pt in the cytosolic fractions was highest in the kidney, followed by the tumor, and lowest in the liver when determined as the fractional percentage of the total amount of injected drug (%ID/g). The significance of such cytosolic and CP localization of Pt is not known at this time, but they may be involved in the cytotoxic effects of cisplatin, as this drug is cytotoxic to tumors and kidneys but not to the liver. The localization of cisplatin in the subcellular fractions of liver, kidney, and tumor showed a trend toward being higher after i.v. infusion than after i.v. bolus administration of the drug.

摘要

在给Sprague-Dawley(SD)大鼠静脉注射6mg/kg顺铂(推注和输注)后,对铂的亚细胞定位进行了分析。在对照动物的肝脏和肾脏以及SD大鼠的这些相同器官和肿瘤(Walker 256腺癌)中进行了生物分布研究。获得的结果表明,除了这些组织中的DNA铂化外,大量的铂还掺入染色体蛋白(CP)和胞质组分中。当以注射药物总量的分数百分比(%ID/g)测定时,铂在胞质组分中的定位在肾脏中最高,其次是肿瘤,在肝脏中最低。目前尚不清楚铂在胞质和CP中的这种定位的意义,但它们可能参与顺铂的细胞毒性作用,因为这种药物对肿瘤和肾脏具有细胞毒性,但对肝脏没有细胞毒性。顺铂在肝脏、肾脏和肿瘤亚细胞组分中的定位显示,静脉输注后比静脉推注给药后有更高的趋势。

相似文献

1
Quantitative subcellular distribution of platinum in rat tissues following i.v. bolus and i.v. infusion of cisplatin.静脉推注和顺铂静脉输注后大鼠组织中铂的定量亚细胞分布。
Cancer Chemother Pharmacol. 1990;26(3):188-92. doi: 10.1007/BF02897197.
2
Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma.接种顺铂敏感或耐药免疫球蛋白M免疫细胞瘤的顺铂处理的LOU/M大鼠肿瘤及器官中的铂浓度和DNA加合物水平。
Cancer Res. 1989 Jun 1;49(11):2862-7.
3
cis-Diamminedichloroplatinum (II)-DNA adduct formation in renal, gonadal, and tumor tissues of male and female rats.顺二氯二氨铂(II)在雄性和雌性大鼠的肾脏、性腺及肿瘤组织中与DNA形成加合物的情况。
Cancer Res. 1987 Feb 1;47(3):718-22.
4
Pharmacokinetic and pharmacodynamic analysis of platinum after combined treatment of cisplatin and procainamide hydrochloride in mice bearing P388 leukemia.顺铂与盐酸普鲁卡因胺联合治疗荷P388白血病小鼠后铂的药代动力学和药效学分析
Anticancer Res. 2003 Mar-Apr;23(2B):1509-16.
5
Platinum distribution in intraperitoneal tumors after intraperitoneal cisplatin treatment.
Cancer Chemother Pharmacol. 1990;25(6):389-94. doi: 10.1007/BF00686048.
6
cis-Platinum: subcellular distribution and binding to cytosolic ligands.
Biochem Pharmacol. 1983 Sep 15;32(18):2665-9. doi: 10.1016/0006-2952(83)90073-4.
7
Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the rat.脂质体包裹的顺式 - 双新癸酸根 - 反式 - R,R - 1,2 - 二氨基环己烷铂(II)和顺铂经静脉注射和腹腔注射给予大鼠后的药代动力学
Cancer Chemother Pharmacol. 1992;30(5):365-9. doi: 10.1007/BF00689964.
8
Local distribution into brain tumor and pharmacokinetics of 4-pyridoxate diammine hydroxy platinum, a novel cisplatin derivative, after intracarotid administration in rats with 9L malignant glioma: simultaneous brain microdialysis study.新型顺铂衍生物4-吡啶酸二胺羟基铂经颈内动脉给药后在9L恶性胶质瘤大鼠脑肿瘤中的局部分布及药代动力学:同步脑微透析研究
Biol Pharm Bull. 2000 Dec;23(12):1491-6. doi: 10.1248/bpb.23.1491.
9
Intracellular metabolites of cisplatin in the rat kidney.大鼠肾脏中顺铂的细胞内代谢产物。
Cancer Chemother Pharmacol. 1989;24(2):73-9. doi: 10.1007/BF00263124.
10
[Basic studies on optimal intra-arterial infusion rate of cisplatin].
Gan To Kagaku Ryoho. 1989 Aug;16(8 Pt 2):2788-91.

引用本文的文献

1
Differential effects of cisplatin in proximal and distal renal tubule epithelial cell lines.顺铂对近端和远端肾小管上皮细胞系的不同作用。
Br J Cancer. 1999 Jan;79(2):293-9. doi: 10.1038/sj.bjc.6690047.
2
Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration.
J Neurooncol. 1998 Jan;36(1):31-40. doi: 10.1023/a:1005756023082.
3
Influence of the rate of intravenous administration of eliprodil (SL 82.0715), a new anti-ischaemic agent, on its distribution in rat plasma and tissues.新型抗缺血药物依利罗地(SL 82.0715)静脉给药速率对其在大鼠血浆和组织中分布的影响。

本文引用的文献

1
Subcellular localization of cis-dichlorodiammineplatinum(II) in rat kidney and liver.顺式二氯二氨合铂(II)在大鼠肾脏和肝脏中的亚细胞定位。
Toxicol Appl Pharmacol. 1980 Sep 15;55(2):245-52. doi: 10.1016/0041-008x(80)90086-1.
2
The effect of zinc and copper pretreatment on the binding of gold (I) to hepatic and renal metallothioneins.锌和铜预处理对金(I)与肝脏和肾脏金属硫蛋白结合的影响。
Biochem Pharmacol. 1982 Jun 15;31(12):2153-9. doi: 10.1016/0006-2952(82)90508-1.
3
Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trials.
J Pharmacokinet Biopharm. 1995 Apr;23(2):147-61. doi: 10.1007/BF02354269.
4
Factors affecting human autopsy kidney-cortex and kidney-medulla platinum concentrations after cisplatin administration.顺铂给药后影响人体尸检肾皮质和肾髓质铂浓度的因素。
Cancer Chemother Pharmacol. 1994;34(1):14-22. doi: 10.1007/BF00686106.
5
Morphometric study of the sensory neuron and peripheral nerve changes induced by chronic cisplatin (DDP) administration in rats.大鼠慢性给予顺铂(DDP)后感觉神经元和周围神经变化的形态计量学研究。
Acta Neuropathol. 1992;84(4):364-71. doi: 10.1007/BF00227662.
脑肿瘤化疗:对目前用于II期和III期试验的药物的评估。
Cancer Treat Rep. 1980;64(12):1179-205.
4
The interaction of platinum complexes with nucleosomes investigated with fluorescent probes.用荧光探针研究铂配合物与核小体的相互作用。
Biochim Biophys Acta. 1982 Aug 30;698(2):173-82. doi: 10.1016/0167-4781(82)90133-6.
5
cis- and trans-Diamminedichloroplatinum(II)-mediated cross-linking of chromosomal non-histone proteins to DNA in HeLa cells.
Biochemistry. 1984 Apr 24;23(9):1921-6. doi: 10.1021/bi00304a005.
6
Intracarotid infusion of cis-diamminedichloroplatinum in the treatment of recurrent malignant brain tumors.颈内动脉灌注顺二氯二氨铂治疗复发性恶性脑肿瘤。
Cancer. 1984 Sep 1;54(5):794-9. doi: 10.1002/1097-0142(19840901)54:5<794::aid-cncr2820540503>3.0.co;2-f.
7
cis-Platinum: subcellular distribution and binding to cytosolic ligands.
Biochem Pharmacol. 1983 Sep 15;32(18):2665-9. doi: 10.1016/0006-2952(83)90073-4.
8
Cisplatinum: a review, with special reference to cellular and molecular interactions.顺铂:一篇综述,特别提及细胞与分子相互作用
Agents Actions. 1984 Dec;15(5-6):520-4. doi: 10.1007/BF01966766.
9
Platinum compounds: a new class of potent antitumour agents.铂化合物:一类新型强效抗肿瘤药物。
Nature. 1969 Apr 26;222(5191):385-6. doi: 10.1038/222385a0.
10
Studies on metal-binding proteins of low molecular weight from renal tissue of rabbits exposed to cadmium or mercury.对暴露于镉或汞的家兔肾脏组织中低分子量金属结合蛋白的研究。
Environ Physiol Biochem. 1974;4(4):149-58.